Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01431079 · ClinicalTrials.gov registry record · Phase 4
A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
A Phase 4 study of HPV Vaccine Acceptability, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT01431079 is a Phase 4 study of HPV Vaccine Acceptability that has completed, run by University of Cincinnati. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01431079, a Phase 4 study of HPV Vaccine Acceptability, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health Belief Model to enhance HPV vaccine acceptability, and (3) test the efficacy of the above intervention based on the Health Belief Model by comparing it to a knowledge-based intervention. Approximately five focus groups with ten participants in each group with college students in the ages 18-25 years will be conducted at a large Midwestern University for the qualitative piece. Data will be analyzed for categories and triangulated with previous study to develop a theory based intervention. For the quantitative piece a randomized controlled design with 45 participants in each arm (theory based intervention and knowledge based intervention) will be implemented.
Conditions Studied
Interventions
- BEHAVIORAL HPV vaccine acceptability
Study Locations (1)
Ohio
- Manoj Sharma - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01431079
The ClinicalTrials.gov registry entry for NCT01431079 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HPV Vaccine Acceptability appearing as the primary indexed condition, and to 1 intervention - of which HPV vaccine acceptability is the first listed.
NCT01431079 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01431079 about?
NCT01431079 is a clinical study titled "A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men". The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health...
What is the current status of trial NCT01431079?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2011-09. Estimated completion is 2012-08.
What conditions does trial NCT01431079 study?
This clinical trial studies the following conditions: HPV Vaccine Acceptability.
What interventions are being tested in trial NCT01431079?
The interventions under investigation include: HPV vaccine acceptability (BEHAVIORAL).
Who is sponsoring clinical trial NCT01431079?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01431079 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.